Detecting the effects of thromboprophylaxis: The case of the rogue reviews

British Medical Journal

Volumn 315, Issue 7109, 1997, Pages 665-668

  Petticrew, Mark ^a   Kennedy, Susan C ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEEP VEIN THROMBOSIS; GENERAL SURGERY; LUNG EMBOLISM; META ANALYSIS; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SHORT SURVEY; THROMBOSIS PREVENTION;

EID: 0030931613     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7109.665     Document Type: Short Survey

References (38)

1. Cherington M. Sherlock Holmes: neurologist? Neurology 1987;37:824-5.
2. Maltby JR. Sherlock Holmes and anaesthesia, Can J Anaesth 1988; 35(1):58-62.
3. Dirckx JH. Medicine and literature: Sherlock Holmes and the art of dermatologic diagnosis, J Dermatol Surg Oncol 1979;5:191-6.
4. Craig PC., Memoirs of Sherlock Holmes through the eyes of an ophthalmologist. Trans PA Acad Ophthalmol Otolaryngol 1972:25(1):42-3.
5. Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-46.
6. Campling EA, Devlin HB, Hoile RW, Lunn JN. Report of the national amfidential enquiry into perioperative deaths 1992/1993. London: NCEPOD. 1995.
7. Lowry JC. Thromboembolic disease and thromboprophylaxis in oral and maxillofacial surgery: experience and practice. Br J Oral Maxillofac Surg 1995;33:101-6.
8. Jones DR. Audit of attitudes to and use of postoperative thromboembolic prophylaxis in a regional health authority. Ann R Coll Surg Engl 1991;73:219-21.
9. Gent M, Roberts RS. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest 1986:89(suppl 5):396-100S.
10. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopaedic and urologic surgery. N Engl J Med 1988;318:1162-73.
11. Daures JP, Schved JF, Momas I, Gril JC, Azoulay P, Gremy F. Meta-analysis on randomised trials comparing the results of low molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis [in French], Rev Epidemiol Sante Publique 1989;37: 303-9.
12. Gallus AS, Cade JF, Mills KW, Murphy W. Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results. Thromb Haemost 1992:68:238-44.
13. Lassen MR, Borris LC, Christiansen MM, Schott P, Olsen AD, Sorensen JV, et al. Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysis. Semin Thromb Hemost 1991;17(suppl 3):284-90.
14. Greyer HG. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery, current status and perspectives. Semin Thromb Hemost 1991;17:336-42.
15. Nurmohamed MT, Rosendaal FR, Buller HR, Dekker E, Hommes DW, Vandenbroucke JP, et al. Low-molecular-weight-heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992:340:152-6.
16. Leizorovicz A, Haugh MC, Chapuis F-R, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992;305:913-20.
17. Simonneau G, Leizorowicz A. Comparison of different methods of prevention of venous thrombosis in orthopaedics. Ann Fr Anesth Reanim 1992;11:354-62.
18. Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J. Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis alter total hip arthroplasty. Ann Intern Med 1993;119:1105-12.
19. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993;80:689-704.
20. Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM. Prophylactic agents for venous thrombosis in elective hip surgery: meta-analysis of studies using venographic assessment. Arch Intern Med 1993;153:2221-8.
21. Imperiale TF, Speroff T. A meta-analysis of methods 10 prevent venous thromboembolism following total hip replacement. JAMA 1994;271:1780-5.
22. Green D, Hirsh J, Heit J, Prins M, Davidson B, Leasing AW. Low molecular weight heparin: a critical analysis of clinical trials. Pharmacol Rev 1994;46:89-109.
23. Koch A, Bouges S, Ziegler S, Dinkel H, Daures JP, Victor N. Low molecu- lai weight heparin and imfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analysis. Br J Surg 1917;84:750-9.
24. Borris I.C, Lassen MR. Jensen HP, Andersen BS, Poulsen KA. Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery:clinical and economic considerations. Int. J Clin Pharmacol Ther 1994;32:262-8.
25. O'Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxaparin versus watfarin prophylaxis against deep-vein thrombosis after total hip replacement. Can Med Assoc J 1994;150:1083-90.
26. Kearon C, Hirsch J. Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 1995;155:366-72.
27. Beyth RJ, Landefeld CS. Anticoagulants in older patients: a safety perspective. Drugs Aging 1995;6(1):45-54.
28. Borris LC, Lassen MR. A comparative review of the adverse effect profiles of heparins and heparinoids. Drug Saf 1995;12(1):26-31.
29. Murray DW, Britton AR, Bulstrode CJK. Thromboprophylaxis and death alter total hip replacement. J Bone Joint Surg 1996;76B:863-70.
30. Andaz S, Shields A, Scurr JH. Coleridge-Smith PD. Role of low molecular weight heparins in the prevention and treatment of venous thromboem- bolism after surgery, Phelebology 1994;9:2-7.
31. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in tinprevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med 1994;154(1):67-72.
32. Clagett GP, Anderson FA Jr, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest 1992;102(suppl 4):391-407S.
33. Goldhaber SZ, Morpurgo M. Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO International Society and Federation of Cardiology Task Force. JAMA 1992;268:1727-33.
34. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992;305:567-74.
35. Haas S. European consensus statement on the prevention of venous thromboembolism. Blood Coag Fibrin 1993;4(1):S5-8.
36. Skrabanek P. Nonsensus consensus. Lancet 1990;335:1446-7.
37. Conan Doyle A. Sherlock Holmes: the complele short stories. London: John Murray, 1928.
38. Egger M, Davey Smith G. Misleading meta-analysis. BMJ 1995;310:752-4. (Accepted 26 August 1997)